Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Case Reports

Successful treatment of refractory cold agglutinin syndrome using fixed duration daratumumab, bortezomib and dexamethasone with a sutimlimab bridge

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA - Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
Department of Pathology, University of Maryland School of Medicine, Baltimore, MD
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA - Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA - Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
Department of Pathology, University of Maryland School of Medicine, Baltimore, MD
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA - Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA - Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
Haematologica Early view May 22, 2025 https://doi.org/10.3324/haematol.2025.287410

Abstract

Not available.

Figures & Tables

Article Information

Early view : Case Reports
 
DOI
https://doi.org/10.3324/haematol.2025.287410
Pubmed
40400475
 
Published
2025-05-22
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
327
PDF Downloads
139

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online